JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.

Name: JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
Author: Oh, Yunmoon

JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells. — المؤلف: Oh, Yunmoon — International journal of molecular sciences 20220517

المؤلف: Oh, Yunmoon
النشر: International journal of molecular sciences 20220517
الموضوعات: ATP Binding Cassette Transporter, Subfamily B, Member 1؛ Antimitotic Agents؛ Antineoplastic Agents؛ Cell Line, Tumor؛ Drug Resistance, Neoplasm؛ Humans؛ Janus Kinase 2؛ Janus Kinase Inhibitors